Regulatory T cell Function in Pediatric Lung Injury
小儿肺损伤中的调节性 T 细胞功能
基本信息
- 批准号:8782734
- 负责人:
- 金额:$ 5.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcute Lung InjuryAdolescentAdoptive TransferAdultAffectAlveolarAlveolusAntibodiesApoptosisAttenuatedBiological AssayBirthC57BL/6 MouseCD4 Positive T LymphocytesCell ProliferationCell physiologyCellsCessation of lifeChemotaxisChildChildhoodComplexDataDefectDiseaseDoseEndotoxinsEnzyme-Linked Immunosorbent AssayFellowshipFetal TissuesFlow CytometryGenetic TranscriptionGrowth and Development functionHealthcareHypoxemiaIL2RA geneImmuneImmune responseImmune systemIn VitroIndividualInflammationInflammatoryInjuryInstructionInterleukin-2KineticsKnowledgeLeadLifeLipopolysaccharidesLungLymphocyte SubsetLymphoid TissueMeasuresMediatingMentorsModelingMonoclonal AntibodiesMorbidity - disease rateMusNational Research Service AwardsNeonatalNewborn InfantOutcomePatientsPeripheralPhenotypePhysiciansPlayPneumoniaPopulationPredispositionRecombinant Interleukin-2RecoveryRegulatory T-LymphocyteResearchResolutionRespiratory FailureRoleScientistSourceSpleenStructure of parenchyma of lungSupportive careTermination of pregnancyTherapeutic InterventionThymus GlandTimeTitrationsTrainingUmbilical Cord Bloodage relatedcareerclinically significantfallsfetalimprovedin vivoinjuredinsightintraperitoneallung injurymigrationmolecular phenotypemortalitymouse modelneonatal lung injuryneonatenew therapeutic targetnovelnovel therapeuticspreventpublic health relevanceresearch studyresponseskills
项目摘要
DESCRIPTION (provided by applicant): The overall objective of this NRSA Individual Fellowship is to develop skills that will allow the candidate to become a physician-scientist and pursue an academic research career. The applicant and his mentors have devised a training approach that includes both research and didactic instruction. This approach will establish the knowledge and intellectual framework essential for a successful research career. The proposal concerns acute lung injury (ALI) in neonates and juveniles. Pediatric acute lung injury represents a major global source of morbidity and mortality. Pneumonia-associated ALI in neonates accounts for 10% of annual childhood deaths. Despite the healthcare burden associated with this disease, the mechanisms through which pediatric ALI resolves remain unknown. Regulatory T cells (Tregs), a subset of cells in the adaptive immune system that suppresses exuberant immune responses, have been shown to play a critical role in lung injury resolution in an adult mouse endotoxin (LPS) model of ALI. There is, however, little data on the role and function of Tregs in pediatric ALI. Tregs play an important role in fetal life by suppressing auto-reactive immune cells and preventing inflammation that may lead to fetal loss; however, these cells may be functionally impaired in the newborn as the immune system transitions from a tolerant state to a pro-inflammatory one. The candidate has preliminary data showing in neonates, unlike in juvenile mice, alveolar Treg numbers do not increase following LPS- mediated lung injury. Increasing Treg number by adoptive transfer enhances resolution and restores normal growth and development in LPS-injured neonates. The focus of this proposal is to further examine the factors that contribute to the diminished Treg response in neonates with the long term hope of discovering novel therapeutic targets for children with ALI. In Specific Aim 1, the candidate will examine the differences in the Treg response of neonatal and juvenile mice following lung injury. Multicolor flow cytometry will be used to determine Treg kinetics and phenotype. Adoptive Transfer of neonatal Tregs into Treg-depleted adults and suppression assays will measure in vivo and ex vivo Treg function. Specific Aim 2 will define the IL-2/CD25 axis modulation of the neonatal Treg response. The candidate will determine age-dependent IL-2 expression by real time PCR and ELISA. He will also define the ability of exogenous IL-2 administration to expand Treg numbers, increase suppressive function, and enhance acute lung injury resolution. These experiments will explore the mechanisms controlling neonatal Treg function following acute lung injury with the ultimate hope of improving patient outcomes in this lethal disease.
描述(由申请人提供):该 NRSA 个人奖学金的总体目标是培养技能,使候选人能够成为一名医师科学家并从事学术研究职业。申请人和他的导师设计了一种培训方法,包括研究和教学指导。这种方法将建立成功的研究生涯所必需的知识和智力框架。该提案涉及新生儿和青少年的急性肺损伤(ALI)。儿童急性肺损伤是全球发病率和死亡率的一个主要来源。新生儿肺炎相关的 ALI 占每年儿童死亡人数的 10%。尽管这种疾病会造成医疗负担,但小儿 ALI 的解决机制仍不清楚。 调节性 T 细胞 (Treg) 是适应性免疫系统中抑制旺盛免疫反应的细胞子集,已被证明在成年小鼠内毒素 (LPS) ALI 模型中的肺损伤缓解中发挥着关键作用。然而,关于 Tregs 在儿科 ALI 中的作用和功能的数据很少。 Tregs 通过抑制自身反应性免疫细胞并预防可能导致胎儿流产的炎症,在胎儿生命中发挥着重要作用;然而,随着免疫系统从耐受状态转变为促炎状态,这些细胞在新生儿中可能会功能受损。该候选者的初步数据显示,与幼年小鼠不同,新生儿的肺泡 Treg 数量在 LPS 介导的肺损伤后不会增加。通过过继转移增加 Treg 数量可增强 LPS 损伤新生儿的分辨率并恢复正常生长和发育。该提案的重点是进一步研究导致新生儿 Treg 反应减弱的因素,长期希望为 ALI 儿童发现新的治疗靶点。 在具体目标 1 中,考生将检查肺损伤后新生小鼠和幼年小鼠 Treg 反应的差异。多色流式细胞术将用于确定 Treg 动力学和表型。将新生儿 Treg 过继转移至 Treg 耗尽的成人中并进行抑制测定,将测量体内和离体 Treg 功能。具体目标 2 将定义新生儿 Treg 反应的 IL-2/CD25 轴调节。候选人将通过实时 PCR 和 ELISA 确定年龄依赖性 IL-2 表达。他还将定义外源性 IL-2 给药扩大 Treg 数量、增强抑制功能和增强急性肺损伤缓解的能力。这些实验将探索急性肺损伤后控制新生儿 Treg 功能的机制,最终希望改善这种致命疾病的患者预后。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kevin Gibbs其他文献
Kevin Gibbs的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
急性肺损伤中Hippo通路调控肺泡中间过渡态上皮细胞再生分化机制研究
- 批准号:82372185
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
土家药山姜通过调控中性粒细胞胞外捕获网的急性肺损伤保护作用及机制研究
- 批准号:82360846
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
基于“肠肺轴”探讨迷迭香酸通过调控肠道菌群对LPS致急性肺损伤小鼠的保护作用及其机制
- 批准号:32360897
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
肺泡巨噬细胞外泌体miR-122-5p调控肺泡II型上皮细胞自噬在脓毒症急性肺损伤中的作用及机制
- 批准号:82360024
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Preclinical development of a synthetic lung surfactant dry powder aerosol for hypoxemia or acute respiratory distress syndrome patients receiving different modes of ventilation support
用于接受不同通气支持模式的低氧血症或急性呼吸窘迫综合征患者的合成肺表面活性剂干粉气雾剂的临床前开发
- 批准号:
10658610 - 财政年份:2023
- 资助金额:
$ 5.89万 - 项目类别:
Pulmonary Disfunction after Polysubstance Exposure: Mechanistic Identification of Inflammatory Mediators
多物质暴露后的肺功能障碍:炎症介质的机制识别
- 批准号:
10662187 - 财政年份:2022
- 资助金额:
$ 5.89万 - 项目类别:
Testing the feasibility and acceptability of social media and digital therapeutics to decrease vaping behaviors
测试社交媒体和数字疗法减少电子烟行为的可行性和可接受性
- 批准号:
10671544 - 财政年份:2022
- 资助金额:
$ 5.89万 - 项目类别:
Development and Implementation of a Tobacco and ENDS Use Intervention for Adolescents and Young Adults in the Pediatric Hospital
针对儿科医院青少年和年轻人制定和实施烟草和电子尼古丁传送系统使用干预措施
- 批准号:
10621209 - 财政年份:2022
- 资助金额:
$ 5.89万 - 项目类别:
The impact of vaping aerosol exposure on innate pulmonary defense mechanisms in nonhuman primates
电子烟气溶胶暴露对非人灵长类动物先天肺防御机制的影响
- 批准号:
10594499 - 财政年份:2022
- 资助金额:
$ 5.89万 - 项目类别: